Keyphrases
Neuroblastoma
73%
131I-metaiodobenzylguanidine
50%
123I-MIBG
41%
Newly Diagnosed
33%
Positron Emission Tomography
22%
123I-MIBG Scintigraphy
16%
Nuclear Imaging
16%
Retrospective Analysis
16%
18F-FDG Positron Emission Tomography
16%
Pediatric Oncology
16%
Localized Neuroblastoma
16%
Fluoroscopic Imaging
16%
Diagnostic Reference Levels
16%
Level Curves
16%
Single-photon Emission Computed Tomography (SPECT)
14%
Organ Function
13%
Diagnostic Accuracy
12%
Chemotherapy
12%
FDG Positron Emission Tomography/computed Tomography
10%
Positron Emission Tomography-computed Tomography (PET-CT)
9%
Metastasis
6%
Respiratory Function
6%
Progressive Disease
6%
Complete Response
6%
Acute Toxicity
6%
Scintigraphy
5%
Nuclear Medicine
5%
Medicine and Dentistry
Ganglioneuroblastoma
100%
(3 Iodobenzyl)guanidine
65%
Iodine 131
63%
Iodine 123
26%
Positron Emission Tomography
22%
Fluorodeoxyglucose F 18
19%
Scintigraphy
18%
Nuclear Medicine
16%
Childhood Cancer
16%
Diagnostic Accuracy
10%
Metastatic Carcinoma
9%
Chemotherapy
9%
Positron Emission Tomography-Computed Tomography
8%
Recurrent Disease
6%
Fluorine-18
6%
Single-Photon Emission Computed Tomography
6%
Retrospective Study
6%
Single Photon Emission Computed Tomography-Computed Tomography
6%
Acute Toxicity
6%
Radioactive Tracer
5%
Computer Assisted Tomography
5%